The 2020 COVID-19 pandemic has affected every aspect of our activities here, including the running of our outpatient clinic, surgical activities, and eye banking. Moreover, no one yet knows how things will develop with this crisis as we move forward into 2021. Of course, it is imperative that we are constantly ready to deal with any medical needs that the pandemic brings. However, at the same time, we must also think strategically about the future.
This year has brought some good news at our department. Assistant Professor Takefumi Yamaguchi and his group published a study in Science Advances on the relationship between post-keratoplastic corneal endothelial damage and alterations in the aqueous humor. This was a great achievement. We would also like to congratulate Dr. Daisuke Tomida on his promotion to Assistant Professor. His work has focused on clinical activities and basic research with regard to the role of cytokines in tears arising from ocular surface disorders.
November brought news in the media of the planned integration of Tokyo Dental College into Keio University in 2023, which will have come as a surprise to many. While the future direction of our work here remains to be determined, this merger will, no doubt, produce many fundamental, and hopefully positive, changes in the future of Ichikawa General Hospital.